Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study
IntroductionTreatment optimization in people with HIV (PWH) has increasingly focused on reducing drug burden and improving regimen simplicity. However, comparative real-world evidence on dual therapy (DT) vs. triple therapy (TT), and single-tablet regimens (STR) vs. multi-tablet regimens (MTR), rema...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1633968/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849237302475227136 |
|---|---|
| author | Daniele Mengato Giacomo Berti Giacomo Berti Andrea Francavilla Silvia Michielan Linda Cappellazzo Laura Agnoletto Maria Chiara Silvani Marco Chiumente Dario Gregori Maria Mazzitelli Francesca Venturini Anna Maria Cattelan the SIFaCT MOSAICO Study Group Salvatore Agosta Marina Allegrini Marina Assirelli Maria Rita Badagliacca Giuliana Battagin Giorgia Bo Jenny Bolcato Cristina Bitello Raffaella Binazzi Arianna Cadeddu Marila Camboni Francesca Cammalleri Anila Corja Marta Cappellini Linda Cappellazzo Claudia Ciraldo Nicolò de Gennaro Maria Dell'Aera Silvia Enisci Giuseppina Emanuela Fassari Sara Ferrari Gabriele Fabbri Michela Falciani Roberta Fraccaroli Anna Gagliardi Giovanna Gandini Veronica Gonzi Giuseppe Greco Clara La Bruna Stefano Loiacono Kety Luzi Eleonora Magistrelli Marina Malena Paola Marini Andrea Misin Valentina Mureddu Arianna Orcesi Simonetta Palazzini Clara Palmieri Giulia Piazza Mariantonietta Piccoli Fabio Pieraccini Francesco Pomarico Giovanna Rametta Roberta Rampazzo Lucia Rossi Aurora Scazzina Chiara Scolamacchia Martina Tegon Sara Tordi Dario Ventura Salvatore Vitale Anastasia Zoffoli |
| author_facet | Daniele Mengato Giacomo Berti Giacomo Berti Andrea Francavilla Silvia Michielan Linda Cappellazzo Laura Agnoletto Maria Chiara Silvani Marco Chiumente Dario Gregori Maria Mazzitelli Francesca Venturini Anna Maria Cattelan the SIFaCT MOSAICO Study Group Salvatore Agosta Marina Allegrini Marina Assirelli Maria Rita Badagliacca Giuliana Battagin Giorgia Bo Jenny Bolcato Cristina Bitello Raffaella Binazzi Arianna Cadeddu Marila Camboni Francesca Cammalleri Anila Corja Marta Cappellini Linda Cappellazzo Claudia Ciraldo Nicolò de Gennaro Maria Dell'Aera Silvia Enisci Giuseppina Emanuela Fassari Sara Ferrari Gabriele Fabbri Michela Falciani Roberta Fraccaroli Anna Gagliardi Giovanna Gandini Veronica Gonzi Giuseppe Greco Clara La Bruna Stefano Loiacono Kety Luzi Eleonora Magistrelli Marina Malena Paola Marini Andrea Misin Valentina Mureddu Arianna Orcesi Simonetta Palazzini Clara Palmieri Giulia Piazza Mariantonietta Piccoli Fabio Pieraccini Francesco Pomarico Giovanna Rametta Roberta Rampazzo Lucia Rossi Aurora Scazzina Chiara Scolamacchia Martina Tegon Sara Tordi Dario Ventura Salvatore Vitale Anastasia Zoffoli |
| author_sort | Daniele Mengato |
| collection | DOAJ |
| description | IntroductionTreatment optimization in people with HIV (PWH) has increasingly focused on reducing drug burden and improving regimen simplicity. However, comparative real-world evidence on dual therapy (DT) vs. triple therapy (TT), and single-tablet regimens (STR) vs. multi-tablet regimens (MTR), remains limited.MethodsThe MOSAICO study is a multicenter, retrospective observational analysis conducted across 20 centers, including people with HIV on a stable virological suppression who switched antiretroviral therapy between 2017 and 2019. People were followed-up up to 48 months post-switch. Comparative analyses assessed virological suppression (HIV-RNA <50 copies/mL), CD4+ T cell count, CD4/CD8 ratio, and treatment discontinuation. Propensity score weighting was applied to adjust for baseline differences.ResultsFour hundred ninety-one PWH were included. Both DT and triple therapy groups maintained high levels of virological suppression over 48 months (12 months: 97.1% vs. 91.6%; 24 months: 100% vs. 95.6%; 36 months: 100% vs. 96.9%; 48 months: 100% vs. 100%). From 24 months onward, all persons living with HIV remaining on their respective regimens achieved full virological suppression. Immunological recovery (CD4+ count and CD4/CD8 ratio) was comparable across groups, although TT and MTR groups showed greater increases from lower baselines. STRs demonstrated significantly greater treatment durability than MTRs (aHR = 0.56, 95% CI: 0.32–0.97; p = 0.039), while no significant difference in persistence was found between DT and TT. INSTI-based regimens were predominant in DT and MTR arms (DT vs. TT: 84% vs. 46.52%, p < 0.01; MTR vs. STR: 59.38% vs. 47.14%, p < 0.01).DiscussionThe real-world effectiveness of both dual and triple therapies when tailored to appropriate person profiles. STRs offer enhanced long-term persistence compared to MTRs, supporting treatment simplification strategies. These results reinforce the importance of individualized treatment approaches balancing clinical effectiveness with person-centered considerations such as pill burden and tolerability. Limitations include the retrospective design and the lack of quality-of-life data, which may affect interpretation of patient-centered outcomes. Future efforts should expand access to dual-agent STR to further improve Antiretroviral Therapy outcomes. |
| format | Article |
| id | doaj-art-b14792aee946443cb5a262e8897fe8b1 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-b14792aee946443cb5a262e8897fe8b12025-08-20T04:02:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-08-011610.3389/fphar.2025.16339681633968Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO studyDaniele Mengato0Giacomo Berti1Giacomo Berti2Andrea Francavilla3Silvia Michielan4Linda Cappellazzo5Laura Agnoletto6Maria Chiara Silvani7Marco Chiumente8Dario Gregori9Maria Mazzitelli10Francesca Venturini11Anna Maria Cattelan12the SIFaCT MOSAICO Study GroupSalvatore AgostaMarina AllegriniMarina AssirelliMaria Rita BadagliaccaGiuliana BattaginGiorgia BoJenny BolcatoCristina BitelloRaffaella BinazziArianna CadedduMarila CamboniFrancesca CammalleriAnila CorjaMarta CappelliniLinda CappellazzoClaudia CiraldoNicolò de GennaroMaria Dell'AeraSilvia EnisciGiuseppina Emanuela FassariSara FerrariGabriele FabbriMichela FalcianiRoberta FraccaroliAnna GagliardiGiovanna GandiniVeronica GonziGiuseppe GrecoClara La BrunaStefano LoiaconoKety LuziEleonora MagistrelliMarina MalenaPaola MariniAndrea MisinValentina MuredduArianna OrcesiSimonetta PalazziniClara PalmieriGiulia PiazzaMariantonietta PiccoliFabio PieracciniFrancesco PomaricoGiovanna RamettaRoberta RampazzoLucia RossiAurora ScazzinaChiara ScolamacchiaMartina TegonSara TordiDario VenturaSalvatore VitaleAnastasia ZoffoliHospital Pharmacy Unit, Azienda Ospedale-Università Padova, Padova, ItalyHospital Pharmacy Unit, Azienda Ospedale-Università Padova, Padova, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padova, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padova, ItalyPharmaceutical Department, Azienda AUSL of Modena, Modena, ItalyHospital Pharmacy, Hospital of Bolzano (SABES-ASDAA), Bolzano, ItalyHospital Pharmacy Unit, Azienda Ulss 5 Polesana, Rovigo, ItalyHospital Pharmacy Unit, Azienda USL Romagna, Ravenna, ItalySocietà Italiana di Farmacia Clinica e Terapia (SIFaCT), Turin, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padova, ItalyInfectious and Tropical Diseases Unit, Azienda Ospedale-Università Padova, Padova, ItalyHospital Pharmacy Unit, Azienda Ospedale-Università Padova, Padova, ItalyInfectious and Tropical Diseases Unit, Azienda Ospedale-Università Padova, Padova, ItalyIntroductionTreatment optimization in people with HIV (PWH) has increasingly focused on reducing drug burden and improving regimen simplicity. However, comparative real-world evidence on dual therapy (DT) vs. triple therapy (TT), and single-tablet regimens (STR) vs. multi-tablet regimens (MTR), remains limited.MethodsThe MOSAICO study is a multicenter, retrospective observational analysis conducted across 20 centers, including people with HIV on a stable virological suppression who switched antiretroviral therapy between 2017 and 2019. People were followed-up up to 48 months post-switch. Comparative analyses assessed virological suppression (HIV-RNA <50 copies/mL), CD4+ T cell count, CD4/CD8 ratio, and treatment discontinuation. Propensity score weighting was applied to adjust for baseline differences.ResultsFour hundred ninety-one PWH were included. Both DT and triple therapy groups maintained high levels of virological suppression over 48 months (12 months: 97.1% vs. 91.6%; 24 months: 100% vs. 95.6%; 36 months: 100% vs. 96.9%; 48 months: 100% vs. 100%). From 24 months onward, all persons living with HIV remaining on their respective regimens achieved full virological suppression. Immunological recovery (CD4+ count and CD4/CD8 ratio) was comparable across groups, although TT and MTR groups showed greater increases from lower baselines. STRs demonstrated significantly greater treatment durability than MTRs (aHR = 0.56, 95% CI: 0.32–0.97; p = 0.039), while no significant difference in persistence was found between DT and TT. INSTI-based regimens were predominant in DT and MTR arms (DT vs. TT: 84% vs. 46.52%, p < 0.01; MTR vs. STR: 59.38% vs. 47.14%, p < 0.01).DiscussionThe real-world effectiveness of both dual and triple therapies when tailored to appropriate person profiles. STRs offer enhanced long-term persistence compared to MTRs, supporting treatment simplification strategies. These results reinforce the importance of individualized treatment approaches balancing clinical effectiveness with person-centered considerations such as pill burden and tolerability. Limitations include the retrospective design and the lack of quality-of-life data, which may affect interpretation of patient-centered outcomes. Future efforts should expand access to dual-agent STR to further improve Antiretroviral Therapy outcomes.https://www.frontiersin.org/articles/10.3389/fphar.2025.1633968/fullpeople with HIVsingle tablet regimendual therapyHIV treatmentswitch therapyoptimization |
| spellingShingle | Daniele Mengato Giacomo Berti Giacomo Berti Andrea Francavilla Silvia Michielan Linda Cappellazzo Laura Agnoletto Maria Chiara Silvani Marco Chiumente Dario Gregori Maria Mazzitelli Francesca Venturini Anna Maria Cattelan the SIFaCT MOSAICO Study Group Salvatore Agosta Marina Allegrini Marina Assirelli Maria Rita Badagliacca Giuliana Battagin Giorgia Bo Jenny Bolcato Cristina Bitello Raffaella Binazzi Arianna Cadeddu Marila Camboni Francesca Cammalleri Anila Corja Marta Cappellini Linda Cappellazzo Claudia Ciraldo Nicolò de Gennaro Maria Dell'Aera Silvia Enisci Giuseppina Emanuela Fassari Sara Ferrari Gabriele Fabbri Michela Falciani Roberta Fraccaroli Anna Gagliardi Giovanna Gandini Veronica Gonzi Giuseppe Greco Clara La Bruna Stefano Loiacono Kety Luzi Eleonora Magistrelli Marina Malena Paola Marini Andrea Misin Valentina Mureddu Arianna Orcesi Simonetta Palazzini Clara Palmieri Giulia Piazza Mariantonietta Piccoli Fabio Pieraccini Francesco Pomarico Giovanna Rametta Roberta Rampazzo Lucia Rossi Aurora Scazzina Chiara Scolamacchia Martina Tegon Sara Tordi Dario Ventura Salvatore Vitale Anastasia Zoffoli Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study Frontiers in Pharmacology people with HIV single tablet regimen dual therapy HIV treatment switch therapy optimization |
| title | Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study |
| title_full | Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study |
| title_fullStr | Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study |
| title_full_unstemmed | Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study |
| title_short | Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO study |
| title_sort | durability and effectiveness of dual vs triple therapy and tablet simplification in art findings from the italian mosaico study |
| topic | people with HIV single tablet regimen dual therapy HIV treatment switch therapy optimization |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1633968/full |
| work_keys_str_mv | AT danielemengato durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giacomoberti durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giacomoberti durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT andreafrancavilla durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT silviamichielan durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT lindacappellazzo durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT lauraagnoletto durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT mariachiarasilvani durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT marcochiumente durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT dariogregori durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT mariamazzitelli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT francescaventurini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT annamariacattelan durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT thesifactmosaicostudygroup durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT salvatoreagosta durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT marinaallegrini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT marinaassirelli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT mariaritabadagliacca durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giulianabattagin durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giorgiabo durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT jennybolcato durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT cristinabitello durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT raffaellabinazzi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT ariannacadeddu durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT marilacamboni durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT francescacammalleri durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT anilacorja durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT martacappellini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT lindacappellazzo durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT claudiaciraldo durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT nicolodegennaro durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT mariadellaera durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT silviaenisci durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giuseppinaemanuelafassari durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT saraferrari durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT gabrielefabbri durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT michelafalciani durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT robertafraccaroli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT annagagliardi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giovannagandini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT veronicagonzi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giuseppegreco durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT claralabruna durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT stefanoloiacono durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT ketyluzi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT eleonoramagistrelli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT marinamalena durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT paolamarini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT andreamisin durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT valentinamureddu durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT ariannaorcesi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT simonettapalazzini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT clarapalmieri durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giuliapiazza durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT mariantoniettapiccoli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT fabiopieraccini durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT francescopomarico durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT giovannarametta durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT robertarampazzo durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT luciarossi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT aurorascazzina durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT chiarascolamacchia durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT martinategon durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT saratordi durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT darioventura durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT salvatorevitale durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy AT anastasiazoffoli durabilityandeffectivenessofdualvstripletherapyandtabletsimplificationinartfindingsfromtheitalianmosaicostudy |